Bay R 1531 is a tricyclic tryptamine derivative which acts as a selective serotonin receptor 5-HT1A agonist. It was researched unsuccessfully for the treatment of stroke but remains in use for scientific research.[1][2][3][4]
Identifiers | |
---|---|
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C18H26N2O |
Molar mass | 286.419 g·mol−1 |
3D model (JSmol) |
|
| |
|